Intratumoral CD103+ dendritic cells (DCs) are necessary for anti-tumor immunity. Here we evaluated the expression of immune regulators by CD103+ DCs in a murine model of breast cancer and identified expression of TIM-3 as a target for therapy. Anti-TIM-3 antibody improved response to paclitaxel chemotherapy in models of triple-negative and luminal B disease, with no evidence of toxicity. Combined efficacy was CD8+ T cell dependent and associated with increased granzyme B expression; however, TIM-3 expression was predominantly localized to myeloid cells in both human and murine tumors. Gene expression analysis identified upregulation of Cxcl9 within intratumoral DCs during combination therapy, and therapeutic efficacy was ablated by CXCR3 blockade, Batf3 deficiency, or Irf8 deficiency.
Pubmed ID: 29316433 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This unknown targets IgG
View all literature mentionsThis unknown targets IgG
View all literature mentionsThis unknown targets IgG
View all literature mentionsThis monoclonal targets
View all literature mentionsThis monoclonal targets CD117
View all literature mentionsThis monoclonal targets CD123
View all literature mentionsThis monoclonal targets CD141
View all literature mentionsThis monoclonal targets CD1c
View all literature mentionsThis monoclonal targets CD11b (Mac-1)
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets TIM-3
View all literature mentionsThis monoclonal targets CD197
View all literature mentionsThis monoclonal targets CD16 (FcγRIII)
View all literature mentionsThis monoclonal targets HLA-DR
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis unknown targets CXCL9
View all literature mentionsThis monoclonal targets CD163
View all literature mentionsThis monoclonal targets CD4 (Helper / Inducer, T-Cell Marker)
View all literature mentionsThis monoclonal targets CD8 (Suppressor T Cell Marker)
View all literature mentionsThis monoclonal targets CD3 (Early T Cell Marker)
View all literature mentionsThis cocktail targets CD45
View all literature mentionsThis monoclonal targets Pan-Keratin (C11) Mouse mAb
View all literature mentionsThis polyclonal targets Human DC-LAMP
View all literature mentionsThis monoclonal targets Galectin-9
View all literature mentionsThis monoclonal targets TIM-3
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis isotype control targets Trinitrophenol
View all literature mentionsThis isotype control targets HRP
View all literature mentionsThis monoclonal targets CXCR3 (CD183)
View all literature mentionsThis monoclonal targets PD-1 (CD279)
View all literature mentionsThis monoclonal targets IFNAR-1
View all literature mentionsThis monoclonal targets IFNγ
View all literature mentionsThis monoclonal targets IL-12 p75
View all literature mentionsThis monoclonal targets CD8β (Lyt 3.2)
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets TIM-4
View all literature mentionsThis monoclonal targets Galectin-9
View all literature mentionsThis monoclonal targets TIM-3 (CD366)
View all literature mentionsThis monoclonal targets CD66a
View all literature mentionsThis monoclonal targets HMGB1
View all literature mentionsThis monoclonal targets CD366
View all literature mentionsThis monoclonal targets TER-119
View all literature mentionsThis monoclonal targets CD49b
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsThis monoclonal targets CD45R
View all literature mentionsThis monoclonal targets CD3epsilon
View all literature mentionsThis monoclonal targets CD16 / CD32
View all literature mentionsThis monoclonal targets CD366
View all literature mentionsThis monoclonal targets TNF-alpha
View all literature mentionsThis monoclonal targets IFN-gamma
View all literature mentionsThis monoclonal targets CXCL9
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets IL-12/IL-23 p40
View all literature mentionsThis monoclonal targets Ly-6C
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD103
View all literature mentionsThis monoclonal targets CD49b
View all literature mentionsThis monoclonal targets CD317
View all literature mentionsThis monoclonal targets Mouse CD3 Molecular Complex
View all literature mentionsThis monoclonal targets CD69
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets
View all literature mentionsThis monoclonal targets
View all literature mentionsThis monoclonal targets CD8 alpha
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD24
View all literature mentionsThis monoclonal targets Ly-6G
View all literature mentionsMus musculus with name FVB-Tg(C3-1-TAg)cJeg/JegJ from IMSR.
View all literature mentionsMus musculus with name B6.129S(C)-Batf3tm1Kmm/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Irf8tm1.1Hm/J from IMSR.
View all literature mentionsMus musculus with name B6.FVB-Tg(MMTV-PyVT)634Mul/LellJ from IMSR.
View all literature mentionsMus musculus with name FVB/N-Tg(MMTV-PyVT)634Mul/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(Itgax-cre)1-1Reiz/J from IMSR.
View all literature mentionsMus musculus with name FVB/NJ from IMSR.
View all literature mentionsMus musculus with name B6(Cg)-Zbtb46tm1(HBEGF)Mnz/J from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Tg(Itgax-cre)1-1Reiz/J from IMSR.
View all literature mentionsMus musculus with name B6(Cg)-Zbtb46tm1(HBEGF)Mnz/J from IMSR.
View all literature mentionsMus musculus with name FVB-Tg(C3-1-TAg)cJeg/JegJ from IMSR.
View all literature mentionsMus musculus with name B6.Cg-Irf8tm1.1Hm/J from IMSR.
View all literature mentionsMus musculus with name B6.129S(C)-Batf3tm1Kmm/J from IMSR.
View all literature mentionsMus musculus with name C57BL/6J from IMSR.
View all literature mentionsMus musculus with name FVB/NJ from IMSR.
View all literature mentionsMus musculus with name B6.FVB-Tg(MMTV-PyVT)634Mul/LellJ from IMSR.
View all literature mentionsMus musculus with name FVB/N-Tg(MMTV-PyVT)634Mul/J from IMSR.
View all literature mentions